Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-study-published-in-the-lancet-infectious-diseases-concludes-that-a-novel-oral-microencapsulated-live-bacteria-consortia-sim01-alleviates-long-covid-symptoms
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-study-published-in-the-lancet-infectious-diseases-concludes-that-a-novel-oral-microencapsulated-live-bacteria-consortia-sim01-alleviates-long-covid-symptoms

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01) led to significant improvements in gut microbiota composition and alleviation of long COVID symptoms. 

 

The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID. The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.

 

Featured are the research team members. (From left) Miss Raphaela Iris Lau, co-first author of the study and a Hong Kong PhD Fellow at CU Medicine; Professor Siew Ng, Croucher Professor of Medical Sciences at CU Medicine and Director of MagIC; Professor Francis Chan, Dean of Medicine; and Professor Su Qi, co-first author of the study and Research Assistant Professor at the Department of Medicine and Therapeutics of CU Medicine.

A clinical trial conducted by CU Medicine and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01) led to significant improvement in gut microbiota composition and alleviation of long COVID symptoms in recovered COVID-19 patients. The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.

(From left) Miss Raphaela Iris Lau, co-first author of the study and a Hong Kong PhD Fellow at CU Medicine; Professor Siew Ng, Croucher Professor of Medical Sciences at CU Medicine and Director of MagIC; Professor Francis Chan, Dean of Medicine; and Professor Su Qi, co-first author of the study and Research Assistant Professor at the Department of Medicine and Therapeutics of CU Medicine.

World’s first large-scale study discovers an effective treatment for long COVID

 

Long COVID refers to long-term symptoms involving multiple systems and organs that persist in recovered COVID-19 patients. Currently, it affects 40% of these patients worldwide, yet the mechanism remains unknown and effective treatment is lacking.

 

The research team has previously shown that patients with long COVID lacked a series of beneficial gut bacteria, which may contribute to multiple symptoms. Using big data and machine-learning analysis, CUHK developed a patented oral microbiome microencapsulated formula (SIM01). From 2021 to 2022, 463 patients were randomly assigned to receive SIM01 or placebo. At six months, significantly higher proportions of the SIM01 group had experienced alleviation of five key symptoms —gastrointestinal upset, fatigue, difficulty in concentration, memory loss, and general unwellness — compared with the placebo group (the alleviation rates were 70%, 63%, 62%, 42% and 77% respectively). Adverse event rates were similar between groups during treatment. SIM01 also significantly enhanced the diversity and richness of the gut microbiota, promoted the growth of multiple beneficial bacteria, and inhibited potentially pathogenic bacteria, thereby maintaining microbial balance.

 

Maintaining balanced gut microbiota is key in preventing infectious diseases and long-term symptoms

 

Professor Siew Ng, CU Medicine’s Croucher Professor of Medical Sciences and Director of MagIC, stated, “This is the first clinical trial to show that modulation of the gut microbiome can improve long COVID symptoms. The study also highlighted important mechanisms underlying the benefits of SIM01. The intervention not only led to increased gut microbiota diversity, richness and microbial function, but also enhanced the production of metabolites from beneficial gut bacteria, including short-chain fatty acids, which can circulate to the brain. These findings supported the importance of the gut-brain axis, and that modulation of the gut microbiota represents a novel approach to improving neurological symptoms.”

 

Professor Francis KL Chan, Dean of Medicine and Director of the Centre for Gut Microbiota Research at CU Medicine, concluded, “Maintaining balanced gut microbiota is key in preventing emerging infectious diseases and persistent symptoms after recovery from the acute infection. As we are at risk of grappling with a surge in respiratory infections during the winter, the public should consider timely microbiota modulation to reduce the risk of infections and their related long-term symptoms.”

 

The RECOVERY STUDY was supported by the InnoHK initiative, and the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region.

More Press Releases

CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CU Medicine finds benign prostatic hyperplasia patients suffer from up to five times the risk of urological complications after COVID-19 infection

CU Medicine finds benign prostatic hyperplasia patients suffer from up to five times the risk of urological complications after COVID-19 infection

Research
CUHK study estimates half of COVID-19 infections went unrecognised during the Omicron epidemic in Hong Kong

CUHK study estimates half of COVID-19 infections went unrecognised during the Omicron epidemic in Hong Kong

Research
CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

Research
CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

Research
CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

Research
Joint Study Unveils How COVID-19  Adversely Impacts Placenta During Pregnancy

Joint Study Unveils How COVID-19 Adversely Impacts Placenta During Pregnancy

Research
CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

Research
T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

Research
CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and  inpatient progression in older patients living in nursing homes

CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and inpatient progression in older patients living in nursing homes

Research
CUHK finds high intention in Hong Kong to keep wearing masks and using alcohol-based sanitiser but low intention to receive a booster shot in the current era of COVID-19 endemicity

CUHK finds high intention in Hong Kong to keep wearing masks and using alcohol-based sanitiser but low intention to receive a booster shot in the current era of COVID-19 endemicity

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

Symposium
A joint HKU-CUHK study confirms smoking and obesity increase  risk of severe COVID-19 by 65%-81%

A joint HKU-CUHK study confirms smoking and obesity increase risk of severe COVID-19 by 65%-81%

Research
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
CUHK study advises residential care homes for the elderly to maintain current infection control practices

CUHK study advises residential care homes for the elderly to maintain current infection control practices

Research
CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

Research
CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

Research
HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

Health Campaign
A joint HKU-CUHK study finds that smoking  increases the risk of COVID-19

A joint HKU-CUHK study finds that smoking increases the risk of COVID-19

Research
CUHK-HKU collaborative research finds a new inflammatory activation pathway in  blood vessels after SARS-CoV-2 infection

CUHK-HKU collaborative research finds a new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Research
CU Medicine study shows distinct gut microbial profile associated with long COVID

CU Medicine study shows distinct gut microbial profile associated with long COVID

Research
Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Research
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

Research
HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

Research
CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

Research
CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise  Performance of COVID-19 Nucleic Acid Tests

CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise Performance of COVID-19 Nucleic Acid Tests

Research
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and  Identifies Faecal Bacterial Markers for Autism

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
A Global Study Led by CU Medicine and HKUMed Discovers  a Hepatitis C Virus Drug as Potent Treatment for COVID-19

A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.